ÂÜÀòÂÒÂ×

Thomas Lavery is a highly experienced legal professional specializing in patent litigation within the biopharmaceutical field. Currently serving as Senior Patent Litigation Counsel at Sandoz since July 2021, Thomas previously held key positions at Morgan Stanley as Vice President, Biotech Patent Analyst, and at Amgen as Senior Patent Litigation Counsel, where significant achievements included leading patent litigations as both an innovator and as a biosimilar challenger. Prior experience includes notable roles at Goodwin Procter LLP and Kenyon & Kenyon, focusing on complex Hatch-Waxman cases. Early career highlights include a legal fellowship at Creative Commons and work as a Bioinformatics Programmer at the Broad Institute, contributing to foundational research in genetics. Thomas holds a J.D. from Cornell Law School and a BS in Biochemistry from Tufts University.